Women’s Health Case Study
Women’s Health Case Study
You will complete the Aquifer case, Internal Medicine 14: 18-year-old female for pre-college physical, focusing on the “Revisit three months later” for this assignment.
ORDER NOW FOR COMPREHENSIVE, PLAGIARISM-FREE PAPERS
After completing the Aquifer case, you will present the case and supporting evidence in a PowerPoint presentation with the following components:
- Slide 1: Title, Student Name, Course, Date
- Slide 2: Summary or synopsis of Judy Pham’s case
- Slide 3: HPI
- Slide 4: Medical History
- Slide 5: Family History
- Slide 6: Social History
- Slide 7: ROS
- Slide 8: Examination
- Slide 9: Labs (In-house)
- Slide 10: Primary Diagnosis and 3 Differential Diagnoses – ranked in priority
Primary Diagnosis should be supported by data in the patient’s history, exam, and lab results.
- Slide 11: Management Plan: medication (dose, route, frequency), non-medication treatment, tests ordered, education, follow-up/referral.
- Slide 12-16: An evaluation of 5 evidence-based articles applicable to Ms. Pham’s case: evaluate 1 article per slide.
- Include title, author, and year of article
- Brief summary/purpose of the study
- How did the study support Ms. Pham’s case?
Course texts will not count as a scholarly source. If using data from websites you must go back to the literature source for the information; no secondary sources are allowed, e.g. Medscape, UptoDate, etc.
- Slide 17: Reference List
- You will submit the PowerPoint presentation in the Submissions Area by the due date assigned. Name your Case Study Presentation SU_NSG6430_W7_A2_lastname_firstinitial.doc
-
Aquifer__STD.pdf.pdf
Internal Medicine 14: 18-year-old woman for pre-college physical
User: Ariana Amini
Email: aamini@gwu.edu
Date: November 11, 2019 2:19AM
Learning Objectives
The student should be able to:
Obtain a history that differentiates among etiologies of dysuria.
Differentiate /distinguish signs and symptoms of lower versus upper urinary tract infection.
Recognize /recommend when to order diagnostic and laboratory tests in evaluation of dysuria, including urinalysis, wet prep, and KOH stain.
Describe current recommendations for cervical cancer screening.
Discuss safe sexual practices and efficacy of common methods of contraception. Women’s Health Case Study
Knowledge
Adolescent Interview – Safety
Violence
The leading causes of death in older adolescents are violent: suicide, injuries, and homicide. Bullying, family violence, sexual abuse, date rape and
school violence are all common. In many urban communities, up to one in four students report carrying a weapon to school. Family violence and
dating violence cross all economic and social boundaries.
Injuries
For some teens, school violence and guns are the major risks, and in others, sports injuries and injuries from wheeled vehicles are more likely. It is
important to address use of a seat belt and bike helmets with every adolescent.
Even though you address the safety issues most prevalent in the patient’s community first, do not skip any part of the history based on assumptions
about the patient’s ethnic background or economic status.
Recommended Vaccinations for Adolescents and Teenagers
MMR
MMR is recommended in adults who have not been previously vaccinated as children. An exception to this recommendation is the
case of pregnant women. Pregnant women should not be vaccinated with MMR because of a risk of fetal transmission since it is a
live virus vaccine.
Hepatitis B Hepatitis B vaccination is effective in preventing hepatitis B virus infection and its sequelae of cirrhosis and hepatic carcinoma. The
series of three injections is recommended for adolescents if they did not receive them when younger.
Meningococcal
The meningococcal vaccine is given to prevent meningococcal meningitis. It is commonly given once at age 11-12 years during the
routine preadolescent immunization visit with a booster dose at age 16 and is recommended for all previously unvaccinated
adolescents aged 11-18 years.
Human
papillomavirus
There are two different human papillomavirus vaccines available. They vary by the number of strains of HPV they protects against,
ranging from four to nine, and can prevent most cases of cervical cancer and genital warts. It is recommended for girls and women
9-26 years old.
The Advisory Committee on Immunization Practices (ACIP) recommends the use of the HPV vaccine in males 11 or 12 years of age.
ACIP also recommends vaccination in males ages 13 through 21 who have not been vaccinated previously or who have not
completed the three-dose series. ACIP states that males aged 22 through 26 years may be vaccinated, but does not recommend routine vaccination in this age group. Women’s Health Case Study
Tetanus,
diphtheria,
acellular
pertussis
The tetanus, diphtheria, acellular pertussis (Tdap) vaccine protects against tetanus, diphtheria and pertussis. It contains acellular
pertussis vaccine (ap), which is less reactogenic than the older whole-cell pertussis vaccine that caused high fever and neurologic
symptoms when given to older children and adults. Tdap, which was licensed in 2005, is the first vaccine for adolescents and adults
that protects against all three diseases.
Adolescents should receive a single dose of Tdap as a booster between the ages of 11 and 18, with the preferred timing between 11
and 12 years. If a patient has received a Td booster, then waiting at least five years between Td and Tdap is encouraged because
the incidence of side effects is lower.
The exception to this rule is the case of type III hypersensitivity reactions. Type III hypersensitivity reactions (Arthus reactions), which
© 2019 Aquifer 1/9
https://www.coursehero.com/file/54387982/Aquifer-STDpdf/
Th is
stu dy
re so
ur ce
w as
sh are
d v ia
Co ur
se He
ro .co
m
are characterized by immune complex deposition in blood vessels, can rarely be seen following receipt of tetanus toxoid or
diphtheria toxoid-containing vaccines. These reactions are characterized by severe pain, swelling, and sometimes necrosis at the
injection site and occur between 4 and 12 hours following vaccination. It is recommended that patients who have had such a type III
hypersensitivity reaction avoid receiving a tetanus toxoid-containing vaccine more frequently than every 10 years.
Varicella
The varicella vaccine series, which is a live virus vaccine, should be given to adolescents who have never had chickenpox or have
not received the vaccine.
Varicella was added to the list of standard childhood vaccines in 1995. Two doses are required, with the first administered at 12-15
months of age and the second at 4-6 years of age. There is also a combination measles, mumps, rubella, and varicella vaccine
(MMRV) available.
Influenza
The influenza vaccine is recommended for everyone who is at least age six months. It is usually administered in September through
December when the influenza season is imminent.
The H1N1 strain, or “swine” influenza, the predominant strain circulating in the U.S. over the past several years, has high rates of
morbidity and mortality among children and adolescents.
Pneumococcal The pneumococcal vaccine is indicated for adolescents with certain chronic health conditions.
Haemophilus
influenzae type
b
Haemophilus influenzae type b vaccine protects against meningitis, pneumonia, epiglottitis, and bacteremia in infants and young
children, but it is not recommended after the age of five years.
When a Pelvic Examination Is Indicated
Cervical cancer screening should start at age 21 regardless of sexual activity and should continue through the age of 65. There is recent
evidence that screening for cervical cancer in women less than 21 years of age leads to procedures and more harm than benefit. The frequency of
cervical cancer screening with the Papanicolaou (Pap) test for immunocompetent individuals with previously normal tests is once every three years
or, for women ages 30 to 65 years, screening with a combination of cytology and human papillomavirus (HPV) testing every five years. Women’s Health Case Study
STI Screening Recommendations
Current recommendations are for all patients age 15 to 65 years to be screened for HIV infection.
Test results for some STIs such as gonorrhea must be reported to the public health department.
Most Common Causes of Cystitis
E. coli causes a majority of all cases of uncomplicated urinary tract infections.
Other common organisms include Staphylococcus saprophyticus, Klebsiella pneumonia, and Proteus mirabilis.
Differentiating Cystitis from Pyelonephritis
It is important to make the distinction between cystitis and pyelonephritis because the treatment differs.
Cystitis Pyelonephritis
Clinical
manifestations
dysuria, frequency, urgency,
suprapubic pain, and/or
hematuria
may or may not have symptoms of cystitis together with fever (> 38ºC) and other systemic
symptoms such as, chills, flank pain, costovertebral angle tenderness, and nausea/vomiting
Urinalysis pyuria pyuria, white blood cell casts (pathognomonic)
Treatment
short-course antibiotic therapy
(three days);
hospitalization usually not
required
at least seven days of treatment;
hospitalization may be required
Dysuria in Males
Disease Presentation Diagnosis
© 2019 Aquifer 2/9
https://www.coursehero.com/file/54387982/Aquifer-STDpdf/
Th is
stu dy
re so
ur ce
w as
sh are
d v ia
Co ur
se He
ro .co
m
UTI and
cystitis
Isolated acute cystitis is rare in males because their longer urethra hinders
bacteria from reaching the bladder, and prostatic fluid has antibacterial
properties.
Most males with acute cystitis have functional or anatomic abnormalities, and
need further evaluation.
Symptoms of lower and upper tract infections are the same in males and
females.
Midstream culture and sensitivity of the urine
Urethritis
Usually sexually transmitted gonococcal and/or chlamydia infection.
Gonococcal urethritis is more likely in males with acute symptoms and
purulent urethral discharge.
Chlamydia is likely when dysuria is present alone or with minimal discharge.
Males with chlamydia infection may be asymptomatic.
Recommended that patients be treated presumptively for both gonorrhea and
chlamydia, pending results.
Herpes simplex virus is a rare cause of urethritis, but may be suggested by
the history of penile lesions.
Diagnosis can be made on a gram stain of
a urethral swab.
Leukocytes and gram-negative
intracellular diplococci confirm the
diagnosis of gonorrhea.
White cells without organisms suggest
non-gonococcal urethritis (NGU) which is
usually chlamydia but can also be
Trichomonas vaginalis.
Because many outpatient offices are not
equipped to do gram stains, NAAT testing
of the urethra or urine is becoming the
preferred diagnostic test for gonorrhea
and chlamydia.